Drug Shortage Report for DEXAMETHASONE-OMEGA

Last updated on 2021-02-25 History
Report ID 133096
Drug Identification Number 02204266
Brand name DEXAMETHASONE-OMEGA
Common or Proper name Dexamethasone Sodium Phosphate Injection USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 4MG
Dosage form(s) LIQUID
Route of administration INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION
Packaging size 10 x 1mL vial/fiole
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-12-14
Estimated end date Unknown
Actual end date 2021-02-05
Shortage status Resolved
Updated date 2021-02-25
Company comments On Allocation.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-02-25 French Compare
v3 2021-02-25 English Compare
v2 2021-02-02 French Compare
v1 2021-02-02 English Compare

Showing 1 to 4 of 4